Nevro Corp - Company Profile
Powered by 
All the data and insights you need on Nevro Corp in one report.
$295
- Save hours of research time and resources with
our up-to-date Nevro Corp Strategy Report
- Understand Nevro Corp position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Nevro Corp (Nevro) is a medical device company, which is engaged in developing novel products that advance the quality of life for people suffering from chronic pain in trunks and limbs. The company has developed Nevro Senza spinal cord stimulation (SCS) system, a non-pharmacological neuromodulation platform for the treatment of chronic pain. The Nevro Senza SCS system is commercially available in the US, Europe, and Australia. The company offers products under Senza, Senza II, Senza Omnia and the Nevro logo brands. Nevro is developing HF10 therapy for treatment related to painful diabetic neuropathy and non-surgical refractory back pain. Nevro is headquartered in Redwood City, California, the US.
Headquarters
United States of America
Address
1800 Bridge Parkway, Redwood City, California, 94065
Website
www.nevro.com
Telephone
1 650 2510005
No of Employees
1,215
Industry
Medical Equipment
Ticker Symbol & Exchange
NVRO (NYSE)
Revenue (2022)
$425.2M
4.6%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-3172.7%
(2022 vs 2021)
Market Cap*
$481.5M
Net Profit Margin (2022)
XYZ
-3,031.1%
(2022 vs 2021)
* As of and is in US$
Nevro Corp premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Senza Spinal Cord Stimulation System | - |
| Senza Omnia | Nevro |
| 10 kHz Therapy | 10 kHz Therapy |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2024 | Regulatory Approval | In February, the company secured approval from the U.S. Food and Drug Administration for a sacroiliac joint fusion device. |
| 2023 | Acquisitions/Mergers/Takeovers | In November, the company acquired Vyrsa Technologies. |
| 2023 | New Products/Services | In March, the company announced the launch of HFX iQ spinal cord stimulation (SCS) system. |
Competitor Comparison
| Key Parameters | Nevro Corp | Abbott Laboratories | Medtronic Plc | Boston Scientific Corp | NeuSpera Medical Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | Ireland | United States of America | United States of America |
| City | Redwood City | Abbott Park | Dublin | Marlborough | San Jose |
| State/Province | California | Illinois | - | Massachusetts | California |
| No. of Employees | 1,215 | 114,000 | 95,000 | 48,000 | - |
| Entity Type | Public | Public | Public | Public | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| D. Keith Grossman | Chairman | Executive Board | 2019 | - |
| Kevin Thornal | Chief Executive Officer; Director; President | Executive Board | 2023 | 49 |
| Roderick H. MacLeod | Senior Vice President; Chief Financial Officer | Senior Management | 2020 | - |
| David Caraway, M.D., Ph.D. | Chief Medical Officer | Senior Management | 2014 | - |
| Julie Dewey | Chief Corporate Communications and Investor Relations Officer | Senior Management | 2020 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward